Grant RDF

• 158
• 159
• 160
• 161
• 162
• 163
• 164
• 165
• 166
• 167
• 168
• 169
• 170
• 171
• 172
• 173
• 174
• 175
• 176
• 177
• 178
• 179
• 180
• 181
• 182
• 183
• 184
• 185
• 186
• 187
• 188
• 189
• 190
• 191
• 192
• 193
• 194
• 195
• 196
• 197
• 198
• more...

• Novel Mechanism of TNFR1 Regulation in Macrophage Apoptosis and Atherogenesis
• Novel Mechanisms of Cardiac Function and Dysfunction
• Novel Mechanisms of Decreased NO Bioavailability in Sickle Cell Nephropathy
• Novel Mechanisms of HDAC1 Regulation of Renal Collecting Duct Function
• Novel Mechanisms of Nitric Oxide Activation in the Kidney
• Novel Metastable Phases and Kinetic Studies in Transition Metals and Alloys under Terapascal Pressures
• Novel Method for Anchoring Osteoinductive Factors to Bone Graft Materials to Enhance Osseointegration
• Novel Methods for Cardiac Micro-Impedance Measurement
• Novel Methods to Detect Gene-Environment Interactions in Treatment-Related Brain Tumors Among Childhood Cancer Survivors
• Novel MRI Techniques to Image Hippocampal Internal Architecture
• Novel Regulators of Fibroblast Growth Factor 23 in Chronic Kidney Disease: Iron Deficiency and Hypoxia
• Novel Role for Shed Syndecan 1 in Promoting an Aggressive Tumor Phenotype
• Novel Sulindac Derivatives for Colon Cancer Chemoprevention
• Novel Therapeutic Approaches for Treatment of CF Patients with W1282X Premature Termination Codon Mutations
• Novel Therapeutic Targets for Fluoroacetate-induced Toxicities
• Novel Therapeutics For Acquired Thrombotic Thrombocytopenic Purpura
• Novel Therapeutics of Acquired Thrombotic Thrombocytopenic Purpura
• Novel Therapies for Chronic Allograft Dysfunction in Children
• Novel Therapies for Chronic Allograft Dysfunction in Children
• Novel Therapies to Modulate the Inflammatory Alloresponse in Renal Grafts
• Novel Therapies to Modulate the Inflammatory Alloresponse in Renal Grafts
• Novel Treatment of NF-1 Associated Malignant Peripheral Nerve Sheath Tumors
• Novel Treatments of Chlorine Induced Injury to the Cardio-Respiratory Systems
• Novel, Middle and Long Wave Infrared Laser Sources for Accelerator Applications
• Novel, Middle and Long Wave Infrared Lasers for Particle Accelerator and X-ray Generation Applications
• Nphp4 and Bbs5 are Required for Ciliary Mediated Cell Signaling Events that Regulate Cardiac Development in the Mouse
• NR4A Orphan Receptors and Insulin Resistance
• NRG Oncology Member Institution Clinical Trial Fixed Price Subaward Agreement
• NRG Oncology Network Group Operations Center
• NRG Oncology Network Group Operations Center: Gynecologic Oncology Cancer Committee Chair

• 158
• 159
• 160
• 161
• 162
• 163
• 164
• 165
• 166
• 167
• 168
• 169
• 170
• 171
• 172
• 173
• 174
• 175
• 176
• 177
• 178
• 179
• 180
• 181
• 182
• 183
• 184
• 185
• 186
• 187
• 188
• 189
• 190
• 191
• 192
• 193
• 194
• 195
• 196
• 197
• 198
• more...